(Q57220869)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Consumers' reports on the health effects of direct-to-consumer drug advertising (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Consumers' Reports On The Health Effects Of Direct-To-Consumer Drug Advertising (English)

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

18 March 2024

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

18 March 2024

author name string

David Blumenthal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Kinga Zapert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Michael Newman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Robert Leitman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Joel S. Weissman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14527237

18 March 2024

Alvin J. Silk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14527237

18 March 2024

language of work or name

English

0 references

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://www.healthaffairs.org/doi/10.1377/hlthaff.W3.82

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

18 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

Suppl Web Exclusives

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

W3-82-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

Physician motivations for nonscientific drug prescribing.

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Physician motivations for nonscientific drug prescribing.

18 March 2024

2

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Promotion of prescription drugs to consumers.

18 March 2024

3

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Promotion of prescription drugs to consumers.

18 March 2024

4

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Direct-to-consumer prescription drug advertising: trends, impact, and implications

18 March 2024

5

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Direct-to-consumer prescription drug advertising: trends, impact, and implications

18 March 2024

6

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Direct-to-consumer prescription drug advertising: trends, impact, and implications

18 March 2024

7

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Direct-to-consumer prescription drug advertising: trends, impact, and implications

18 March 2024

8

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Direct-to-consumer prescription drug advertising: trends, impact, and implications

18 March 2024

9

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Direct-to-consumer prescription drug advertising: trends, impact, and implications

18 March 2024

10

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Direct-to-consumer prescription drug advertising: trends, impact, and implications

18 March 2024

11

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey

18 March 2024

14

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey

18 March 2024

15

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey

18 March 2024

16

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey

18 March 2024

17

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey

18 March 2024

18

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Understanding the managed care backlash

18 March 2024

22

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

For and against: Direct to consumer advertising is medicalising normal human experience: For.

18 March 2024

27

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

28

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

29

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

30

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

31

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

32

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

33

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

34

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

35

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

36

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

37

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey

18 March 2024

38

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

The Effects of Response Rate Changes on the Index of Consumer Sentiment

18 March 2024

42

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

The Effects of Response Rate Changes on the Index of Consumer Sentiment

18 March 2024

43

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

The Effects of Response Rate Changes on the Index of Consumer Sentiment

18 March 2024

44

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

Journal of the National Medical Association

18 March 2024

47

94

194

Allison-Ottey S.D.

2002

1 reference

https://api.crossref.org/works/10.1377/HLTHAFF.W3.82

18 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14527237%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference